Reading Time: 9 minutes I’m sure many of you who follow our blog have also been following the discussion on our forum about the Neuraltus trial for a drug called NP001.
Category: Clinical Trials
Reading Time: < 1 minute I’m glad to finally announce that UK recruitment for the dexpramipexole clinical trial is now open! So far, we are aware that Liverpool has opened
Reading Time: < 1 minute We’re aware that thing’s may seem quiet in terms of ‘big’ MND research moments… almost too quiet… Well, today, the pharmaceutical companies Biogen Idec and Knopp Biosciences announced
Reading Time: 2 minutes One human neural stem cell line that has cleared the US Government’s regulatory hurdles is that developed by the biotechnology company Neuralstem. To date, nine
Reading Time: 2 minutes The remainder of the morning covered some of the preclinical research that has laid the foundations for current and forthcoming clinicalstudies. Prof Clive Svendsen, from University Wisconsin-Madison, gave an
Reading Time: 2 minutes This year, two sessions are related to clinical trials. The first, concerns the planning and design of clinical trials. The second is the results of
Reading Time: < 1 minute Sharing information at the symposium is what it’s all about. Today, Randall Kaye, chief medical officer from Avanir Pharmaceuticals, chose the symposium to give a presentation on
Reading Time: 2 minutes Last weekend 19 neurologists and researchers gathered in a hotel seminar room in The Netherlands to talk about building closer links across Europe. Prof Leonard
Reading Time: 3 minutes Day 2 began early! By 8.15am our stand was on display in the ‘breakout’ room, where the tea and lunch breaks were held and also
Reading Time: < 1 minute GlaxoSmithKline (GSK), the pharmaceutical giant, is now recruiting for a clinical trial–often referred to as the NOGO trial. The drug being tested is called ‘GSK1223249’ which isn’t the